Skip to content

Measurement of High Blood Pressure Using Boppli

Improving the Measurement of Neonatal High Blood Pressure Using the Boppli Device

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07547917
Enrollment
30
Registered
2026-04-23
Start date
2026-04-30
Completion date
2031-06-01
Last updated
2026-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Neonatal

Brief summary

This study evaluates a new, non-invasive device (Boppli™) that continuously measures blood pressure in newborn infants. The study compares Boppli measurements to standard blood pressure cuff measurements to determine how well the device works and whether it improves identification of high blood pressure in infants in the neonatal intensive care unit (NICU). The study also includes follow-up through 1 year of age to understand longer-term outcomes.

Detailed description

High blood pressure in newborn infants (neonatal hypertension) is increasingly recognized but remains difficult to diagnose. There is no single standard definition, and current blood pressure measurements rely on intermittent cuff-based methods. These cuff measurements can be affected by infant movement, agitation, and measurement technique, which may lead to inaccurate classification of blood pressure. The Boppli™ device is a non-invasive monitoring system that uses a soft band placed on the infant to continuously measure blood pressure using pulse wave signals. Unlike standard cuffs, the device does not inflate and may reduce measurement-related variability. This is a prospective observational study conducted in infants admitted to the NICU who are less than 5 kg and are at risk for high blood pressure or have clinical concern for elevated blood pressure. The study does not change clinical care, and Boppli measurements will not be used for medical decision-making. The study has three parts: Part 1: Feasibility and Comparison of Measurements Infants will wear the Boppli device for up to 72 hours while standard blood pressure cuff measurements are collected as part of routine care. Measurements from the two methods will be compared to evaluate how closely they agree. The study will also assess how easy the device is to use and how well it is tolerated by infants, families, and clinical staff. Part 2: Effect of Cuff Measurements on Blood Pressure Infants will continue Boppli monitoring for 72 hours. Blood pressure cuff measurements will be obtained during the first 24 hours, stopped during the second 24 hours, and resumed during the third 24 hours. This design allows the study team to evaluate whether cuff measurements themselves affect blood pressure readings. The ability of the Boppli device to identify high blood pressure will be compared to cuff-based definitions. Part 3: Follow-up After Hospital Discharge (Exploratory) Infants with concern for high blood pressure during hospitalization will be followed through 1 year of age. Blood pressure, growth, and clinical outcomes will be collected from routine clinic visits or study visits. This part of the study will evaluate whether early blood pressure findings persist and whether infants require treatment. The main outcome of the study is whether the Boppli device can be used successfully in the NICU and how well its measurements agree with standard cuff measurements. Additional outcomes include how accurately the device identifies high blood pressure and whether cuff measurements influence blood pressure readings. Longer-term outcomes will describe blood pressure patterns and clinical care during infancy. This study is considered minimal risk. The device is non-invasive, and participation will not affect the medical care infants receive.

Interventions

DEVICEBoppli

The Boppli™ device is a non-invasive, wearable blood pressure monitoring system designed for use in neonates and infants. The device consists of a soft sensor band placed on the infant that continuously measures pulse waveforms to estimate blood pressure without the use of cuff inflation. In this study, the device will be applied for up to 72 hours to collect continuous blood pressure data. Measurements obtained from the device will be recorded for research purposes only and will not be used to guide clinical care or medical decision-making.

Sponsors

Indiana University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

Care teams and providers will be aware of the infant's participation, as the Boppli device will be visible. However, as the Boppli measurements will not be used to impact clinical care, the device screen will be covered to minimize distraction. Nursing staff will periodically confirm proper connection and functioning of the device, without removing the screen cover except as necessary. The devices waveform is visible to ensure measurements are taken.

Intervention model description

This is an observational study of a device for blood pressure measurement in babies with high blood pressure.

Eligibility

Sex/Gender
ALL
Age
0 Months to 9 Months
Healthy volunteers
No

Inclusion criteria

* Admitted to the neonatal intensive care unit (NICU) * Age 0 to 9 months at time of enrollment * Weight less than 5 kg * At risk for elevated blood pressure or with clinical concern for hypertension, -including but not limited to: * History of acute kidney injury or kidney disease * History of extracorporeal membrane oxygenation (ECMO) * Parent or legal guardian able to provide informed consent

Exclusion criteria

* Currently receiving extracorporeal membrane oxygenation (ECMO) * Currently receiving any form of extracorporeal dialysis (e.g., continuous renal -replacement therapy) * Presence of a ventricular assist device * Congenital anomalies or clinical conditions that prevent placement of the Boppli™ device * For Part 2 only: infants not expected to survive hospitalization

Design outcomes

Primary

MeasureTime frameDescription
Feasibility and agreement of Boppli to cuff based measurements72 hoursFeasibility will be assessed by the proportion of successful blood pressure measurements obtained using the Boppli™ device during the monitoring period and user-reported ease of use. Agreement will be assessed by comparing measurements obtained from the Boppli™ device to those obtained from standard cuff-based measurements using paired measurements.

Secondary

MeasureTime frameDescription
Diagnostic accuracy of Boppli™ device for identification of elevated blood pressure72 hoursSensitivity, specificity, positive predictive value, and negative predictive value of Boppli™-derived blood pressure measurements for identifying elevated blood pressure (≥95th percentile for post-menstrual age) compared to standard cuff-based definitions.
Agreement in classification of elevated blood pressure between Boppli™ and cuff measurements72 hoursProportion of infants classified as having elevated blood pressure (≥95th percentile for post-menstrual age) by Boppli™ monitoring compared to classification by standard cuff-based measurements.
User-reported feasibility and acceptability of the Boppli™ device72-144 hoursAssessment of caregiver and clinical staff experience using a voluntary survey evaluating ease of use, device performance, and infant tolerance

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 12, 2026